Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
11.46
-0.39 (-3.29%)
Aug 24, 2026, 4:00 PM EDT - Market closed
Pharming Group Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 815 | 1,147 | 650 | 763 | 756 | 572 | |
Market Cap Growth | -11.88% | 76.58% | -14.84% | 0.93% | 32.18% | -42.41% |
Enterprise Value | 769 | 1,112 | 608 | 728 | 702 | 554 |
Last Close Price | 11.46 | 17.67 | 10.06 | 11.43 | 11.03 | 8.94 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 87.62 | 402.37 | - | - | 55.27 | 35.75 |
PS Ratio | 2.22 | 3.05 | 2.19 | 3.11 | 3.68 | 2.88 |
PB Ratio | 3.01 | 4.14 | 2.94 | 3.49 | 3.69 | 2.96 |
P/TBV Ratio | 5.72 | 8.10 | 4.06 | 5.17 | 5.82 | 5.23 |
P/FCF Ratio | 23.71 | 21.26 | - | - | 35.85 | 21.10 |
P/OCF Ratio | 23.27 | 20.97 | - | - | 33.66 | 15.11 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.10 | 2.96 | 2.05 | 2.97 | 3.41 | 2.78 |
EV/EBITDA Ratio | 23.39 | 28.07 | 188.69 | - | 40.97 | 18.22 |
EV/EBIT Ratio | 30.33 | 33.94 | - | - | 67.70 | 23.07 |
EV/FCF Ratio | 22.38 | 20.61 | - | - | 33.29 | 20.43 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.42 | 0.42 | 0.51 | 0.78 | 0.82 | 0.84 |
Debt / EBITDA Ratio | 3.12 | 2.69 | 17.02 | - | 8.46 | 4.88 |
Debt / FCF Ratio | 3.30 | 2.15 | - | - | 7.91 | 5.97 |
Net Debt / Equity Ratio | -0.17 | -0.23 | -0.25 | -0.19 | -0.20 | -0.16 |
Net Debt / EBITDA Ratio | -1.37 | -1.60 | -17.24 | 2.74 | -2.37 | -0.99 |
Net Debt / FCF Ratio | -1.31 | -1.17 | 21.50 | 2.24 | -1.93 | -1.11 |
Asset Turnover | 0.80 | 0.84 | 0.69 | 0.55 | 0.50 | 0.49 |
Inventory Turnover | 0.77 | 0.75 | 0.63 | 0.51 | 0.50 | 0.87 |
Quick Ratio | 2.31 | 1.97 | 2.96 | 3.28 | 3.90 | 4.69 |
Current Ratio | 3.01 | 2.59 | 3.77 | 4.06 | 4.65 | 5.33 |
Return on Equity (ROE) | 3.65% | 1.02% | -5.38% | -4.98% | 6.88% | 8.50% |
Return on Assets (ROA) | 3.47% | 4.55% | -0.52% | -3.06% | 1.57% | 3.68% |
Return on Invested Capital (ROIC) | 6.76% | 3.41% | -2.10% | -12.76% | 5.79% | 10.98% |
Return on Capital Employed (ROCE) | 6.80% | 8.50% | -1.10% | -5.70% | 2.80% | 6.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.14% | 0.25% | -1.82% | -1.38% | 1.81% | 2.80% |
FCF Yield | 4.22% | 4.70% | -0.40% | -2.46% | 2.79% | 4.74% |
Buyback Yield / Dilution | -12.83% | -11.25% | -2.18% | 7.09% | -0.85% | -2.70% |